rjs, while that is true that $40M would outweigh t
Post# of 36537
(Total Views: 276)
Posted On: 12/05/2019 2:39:31 PM
rjs, while that is true that $40M would outweigh the current market share, however they have been working on this S1 for some time, including when they RETIRED shares (about $50M market cap). So $40M is large compared to where we are, however the $40M at one point was much smaller of an affect. Maybe the investors know this and the GNBT is worth more than the OTC is representing and are willing to still go ahead with that valuation.
Quote:
I thought some investors will be spooked away by hearing of an otc stock that’s struggling to uplist talk of a pending registered offering of $40 mil in equity (which far outweighs market cap.)
Read More: https://investorshangout.com/post/view?id=561...z67GMto9p4
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼